Action Point Financial Planning’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-94
Closed -$20.9K – 872
2026
Q2
$20.9K Buy
+94
New +$16.7K ﹤0.01% 1110

Other funds holding CRL

Action Point Financial Planning's CRL Position: Q3 2026 in Review

Action Point Financial Planning sold out of Charles River Laboratories (CRL) in Q3 2026, closing a stake of 94 shares — an estimated $20.9K sold.

Action Point Financial Planning first reported a position in CRL in Q2 2026 and held it in 1 quarter. The position peaked at $20.9K in Q2 2026. 646 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • Action Point Financial Planning reported no remaining Charles River Laboratories position as of Q3 2026 after selling out during the quarter.
  • Action Point Financial Planning sold 94 Charles River Laboratories shares in Q3 2026, an estimated $20.9K.
  • Action Point Financial Planning first reported a position in Charles River Laboratories in Q2 2026 and held it in 1 quarter.
  • Action Point Financial Planning's Charles River Laboratories position peaked at $20.9K in Q2 2026.
  • 646 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.